Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Frontage Laboratories has entered into an agreement to acquire Quintara Discovery. The transaction is expected to close in the third quarter of 2021. Frontage Labs will finance the transaction through the Company's internal resources.
read more
Frontage Laboratories has announced that they have completed a GLP validation of the Simoa HD-1 Analyzer and software along with the interface to Watson LIMS. Data will be generated, processed and stored in a secure environment meeting the compliance...
read more
Frontage Laboratories has established a joint venture with Zhejiang Jiuzhou Pharmaceutical Co., Ltd. to provide enhanced access to high quality and economical API & intermediate development and manufacturing (CDMO) services to new US clients focused ...
read more
Frontage Laboratories unveiled its newest Contract Research, Development and Manufacturing Organization (CRDMO) facility during a grand open house event held on May 22, 2025, at its campus in Exton, Pennsylvania.
read more
Frontida BioPharm announced the FDA issued a closure letter for its Philadelphia manufacturing site.
read more
Frontier Scientific Solutions announced the appointment of Michelle D’Angelo as Chief Commercial Officer (CCO).
read more
Tuesday, February 11, 2025
Frontier Scientific Solutions announced that construction of its state-of-the-art cGMP temperature-controlled facilities at Wilmington International Airport (ILM) is in full swing with the first vertical structures being installed. This ...
read more
Wednesday, December 19, 2018
Alvotech announced Japan-based Fuji Pharma has acquired a 4.2% stake in the business for approximately $50 million.
read more
Fujifilm has announced the extension of its gene therapy and viral vaccine Fill/Finish capabilities to provide services in support of late phase candidates and commercial supply.
read more
FUJIFILM Biotechnologies has launched ShunzymeX precision purification technology, which simplifies downstream processing for complex biologics
read more
Friday, September 05, 2025
FUJIFILM Biotechnologies announced the appointment of Samuel Hernandez, Ph.D., as senior vice president and site head for its College Station, Texas facility. With over two decades of biotechnology and pharmaceutical leadership experience, Dr. ...
read more
Wednesday, April 15, 2026
FUJIFILM Biotechnologies announced the opening of its new, 2,000 square meter (m2) quality control (QC) laboratory at its Hillerød, Denmark, commercial scale manufacturing site.
read more
Thursday, August 01, 2019
FUJIFILM has completed the acquisition of Biogen (Denmark) Manufacturing ApS, a large-scale biologics manufacturing site located in Hillerød near Copenhagen, Denmark from Biogen.
read more
FUJIFILM Diosynth Biotechnologies has announced an expansion to its United Kingdom location through the creation of a new BioCampus.
read more
FUJIFILM Diosynth Biotechnologies U.S.A., Inc., a Biologics Contract Development and Manufacturing Organization with experience focused on the development and manufacture of recombinant biopharmaceuticals including proteins, vaccines, and monoclonal ...
read more